Distinguished in Endoscopy

Dr. Jaime Landman

Urology
Uci Department Of Urology
101 The City Dr S, 
Orange, CA 
Offers Telehealth
Distinguished in Endoscopy
Uci Department Of Urology
101 The City Dr S, 
Orange, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jaime Landman is an Urologist in Orange, California. Dr. Landman is rated as a Distinguished provider by MediFind in Endoscopy. His top areas of expertise are Kidney Stones, Renal Cell Carcinoma (RCC), Ureterocele, Lithotripsy, and Nephrectomy.

His clinical research consists of co-authoring 192 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 78 articles in the study of Endoscopy.

Specialties
Urology
Licenses
Urology in CA
Hospital Affiliations
Uci Health-Orange
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

UCI DEPARTMENT OF UROLOGY
101 The City Dr S, Orange, CA 92868

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Drug
Study Drugs: Fluticasone Furoate, Vilanterol
Study Phase: Phase 3
Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes
Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes
Enrollment Status: Completed
Publish Date: March 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Crossover Study to Evaluate the Efficacy and Safety of LY3454738 in Adults With Chronic Spontaneous Urticaria Inadequately Controlled With H1-Antihistamines
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Crossover Study to Evaluate the Efficacy and Safety of LY3454738 in Adults With Chronic Spontaneous Urticaria Inadequately Controlled With H1-Antihistamines
Enrollment Status: Terminated
Publish Date: March 11, 2022
Intervention Type: Drug
Study Drug: LY3454738
Study Phase: Phase 2
Prospective Randomized Evaluation of Peri-Ureteral and Intradetrusor Injection of Botulinum Toxin Type A for the Treatment of Ureteral Stent Related Pain and Irritative Voiding Symptoms
Prospective Randomized Evaluation of Peri-Ureteral and Intradetrusor Injection of Botulinum Toxin Type A for the Treatment of Ureteral Stent Related Pain and Irritative Voiding Symptoms
Enrollment Status: Terminated
Publish Date: August 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

192 Total Publications

Ureteral Access Sheath Deployment: Understanding the Force Tolerance of the Human Ureter and the Development of Ureteral Injury During Endoscopic Surgery.
Ureteral Access Sheath Deployment: Understanding the Force Tolerance of the Human Ureter and the Development of Ureteral Injury During Endoscopic Surgery.
Journal: Journal of endourology
Published: November 28, 2025
Similar Doctors
Distinguished in Endoscopy
Dr. Zhamshid Okhunov
Urology
Distinguished in Endoscopy
Dr. Zhamshid Okhunov
Urology

Faculty Physicians And Surgeons Of Llusm

901 San Bernardino Rd, Suite 104and302, 
Upland, CA 
 (26.0 miles away)
909-558-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Zhamshid Okhunov is an Urologist in Upland, California. Dr. Okhunov is rated as a Distinguished provider by MediFind in Endoscopy. His top areas of expertise are Kidney Stones, Renal Cell Carcinoma (RCC), Enlarged Prostate (BPH), Lithotripsy, and Ureteroscopy.

Distinguished in Endoscopy
Dr. Alberto B. Breda
Urology
Distinguished in Endoscopy
Dr. Alberto B. Breda
Urology
10833 Le Conte Avenue, 
Los Angeles, CA 
 (37.0 miles away)
310-303-6204
Languages Spoken:
English

Alberto Breda is an Urologist in Los Angeles, California. Dr. Breda is rated as an Elite provider by MediFind in Endoscopy. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Bladder Cancer, Nephrectomy, and Ureteroscopy.

Distinguished in Endoscopy
Dr. Ralph V. Clayman
Urology
Distinguished in Endoscopy
Dr. Ralph V. Clayman
Urology

Uci Department Of Urology

101 The City Dr S, 
Orange, CA 
 (0.1 miles away)
714-456-6054
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ralph Clayman is an Urologist in Orange, California. Dr. Clayman is rated as a Distinguished provider by MediFind in Endoscopy. His top areas of expertise are Kidney Stones, Perirenal Abscess, Boils, Ureteroscopy, and Lithotripsy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Landman's expertise for a condition
ConditionClose
View All 18 Distinguished Conditions
View All 12 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile